nodes	percent_of_prediction	percent_of_DWPC	metapath
Vigabatrin—GABBR1—cortex of kidney—kidney cancer	0.0174	0.0989	CbGeAlD
Vigabatrin—GABBR1—cardiac atrium—kidney cancer	0.0166	0.0941	CbGeAlD
Vigabatrin—SLC36A1—nephron tubule—kidney cancer	0.016	0.0908	CbGeAlD
Vigabatrin—ABAT—nephron tubule—kidney cancer	0.0159	0.0902	CbGeAlD
Vigabatrin—L-Glutamine—CCBL1—kidney cancer	0.0156	0.513	CrCbGaD
Vigabatrin—SLC36A1—renal system—kidney cancer	0.0146	0.0825	CbGeAlD
Vigabatrin—ABAT—renal system—kidney cancer	0.0145	0.082	CbGeAlD
Vigabatrin—SLC36A1—kidney—kidney cancer	0.0141	0.0798	CbGeAlD
Vigabatrin—ABAT—kidney—kidney cancer	0.014	0.0793	CbGeAlD
Vigabatrin—SLC36A1—cortex of kidney—kidney cancer	0.0137	0.0777	CbGeAlD
Vigabatrin—ABAT—cortex of kidney—kidney cancer	0.0136	0.0772	CbGeAlD
Vigabatrin—SLC36A1—gonad—kidney cancer	0.0131	0.074	CbGeAlD
Vigabatrin—ABAT—gonad—kidney cancer	0.013	0.0735	CbGeAlD
Vigabatrin—L-Glutamine—PPAT—kidney cancer	0.00762	0.251	CrCbGaD
Vigabatrin—L-Glutamine—TGM2—kidney cancer	0.00717	0.236	CrCbGaD
Vigabatrin—Dermatitis—Everolimus—kidney cancer	0.000516	0.000651	CcSEcCtD
Vigabatrin—Headache—Vinblastine—kidney cancer	0.000516	0.00065	CcSEcCtD
Vigabatrin—Angioedema—Paclitaxel—kidney cancer	0.000515	0.000649	CcSEcCtD
Vigabatrin—Purpura—Doxorubicin—kidney cancer	0.000514	0.000648	CcSEcCtD
Vigabatrin—Headache—Everolimus—kidney cancer	0.000514	0.000648	CcSEcCtD
Vigabatrin—Abdominal pain—Dactinomycin—kidney cancer	0.000513	0.000646	CcSEcCtD
Vigabatrin—Body temperature increased—Dactinomycin—kidney cancer	0.000513	0.000646	CcSEcCtD
Vigabatrin—Visual impairment—Capecitabine—kidney cancer	0.000512	0.000646	CcSEcCtD
Vigabatrin—Asthenia—Sorafenib—kidney cancer	0.000511	0.000644	CcSEcCtD
Vigabatrin—Malaise—Paclitaxel—kidney cancer	0.000508	0.000641	CcSEcCtD
Vigabatrin—Vertigo—Paclitaxel—kidney cancer	0.000506	0.000638	CcSEcCtD
Vigabatrin—Lethargy—Doxorubicin—kidney cancer	0.000505	0.000637	CcSEcCtD
Vigabatrin—Hypersensitivity—Sunitinib—kidney cancer	0.000505	0.000636	CcSEcCtD
Vigabatrin—Decreased appetite—Vincristine—kidney cancer	0.000504	0.000635	CcSEcCtD
Vigabatrin—Pruritus—Sorafenib—kidney cancer	0.000504	0.000635	CcSEcCtD
Vigabatrin—Vomiting—Erlotinib—kidney cancer	0.000503	0.000634	CcSEcCtD
Vigabatrin—Erythema multiforme—Capecitabine—kidney cancer	0.000502	0.000633	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000501	0.000631	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Vincristine—kidney cancer	0.0005	0.00063	CcSEcCtD
Vigabatrin—Fatigue—Vincristine—kidney cancer	0.000499	0.00063	CcSEcCtD
Vigabatrin—Rash—Erlotinib—kidney cancer	0.000499	0.000629	CcSEcCtD
Vigabatrin—Dermatitis—Erlotinib—kidney cancer	0.000498	0.000628	CcSEcCtD
Vigabatrin—Insomnia—Gemcitabine—kidney cancer	0.000497	0.000627	CcSEcCtD
Vigabatrin—Eye disorder—Capecitabine—kidney cancer	0.000497	0.000626	CcSEcCtD
Vigabatrin—Headache—Erlotinib—kidney cancer	0.000496	0.000625	CcSEcCtD
Vigabatrin—Tinnitus—Capecitabine—kidney cancer	0.000495	0.000625	CcSEcCtD
Vigabatrin—Pain—Vincristine—kidney cancer	0.000495	0.000624	CcSEcCtD
Vigabatrin—Constipation—Vincristine—kidney cancer	0.000495	0.000624	CcSEcCtD
Vigabatrin—Osteoarthritis—Doxorubicin—kidney cancer	0.000495	0.000624	CcSEcCtD
Vigabatrin—Diplopia—Doxorubicin—kidney cancer	0.000495	0.000624	CcSEcCtD
Vigabatrin—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000495	0.000624	CcSEcCtD
Vigabatrin—Pain in extremity—Doxorubicin—kidney cancer	0.000495	0.000624	CcSEcCtD
Vigabatrin—Paraesthesia—Gemcitabine—kidney cancer	0.000493	0.000622	CcSEcCtD
Vigabatrin—Cough—Paclitaxel—kidney cancer	0.000492	0.00062	CcSEcCtD
Vigabatrin—Asthenia—Sunitinib—kidney cancer	0.000491	0.000619	CcSEcCtD
Vigabatrin—Nausea—Vinblastine—kidney cancer	0.000489	0.000616	CcSEcCtD
Vigabatrin—Somnolence—Gemcitabine—kidney cancer	0.000489	0.000616	CcSEcCtD
Vigabatrin—Convulsion—Paclitaxel—kidney cancer	0.000488	0.000616	CcSEcCtD
Vigabatrin—Affect lability—Doxorubicin—kidney cancer	0.000487	0.000614	CcSEcCtD
Vigabatrin—Nausea—Everolimus—kidney cancer	0.000487	0.000614	CcSEcCtD
Vigabatrin—Diarrhoea—Sorafenib—kidney cancer	0.000487	0.000614	CcSEcCtD
Vigabatrin—Pruritus—Sunitinib—kidney cancer	0.000485	0.000611	CcSEcCtD
Vigabatrin—Arthralgia—Paclitaxel—kidney cancer	0.00048	0.000605	CcSEcCtD
Vigabatrin—Chest pain—Paclitaxel—kidney cancer	0.00048	0.000605	CcSEcCtD
Vigabatrin—Myalgia—Paclitaxel—kidney cancer	0.00048	0.000605	CcSEcCtD
Vigabatrin—Anxiety—Paclitaxel—kidney cancer	0.000478	0.000603	CcSEcCtD
Vigabatrin—Face oedema—Doxorubicin—kidney cancer	0.000478	0.000603	CcSEcCtD
Vigabatrin—Decreased appetite—Gemcitabine—kidney cancer	0.000478	0.000602	CcSEcCtD
Vigabatrin—Hypersensitivity—Dactinomycin—kidney cancer	0.000478	0.000602	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000477	0.000601	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000474	0.000598	CcSEcCtD
Vigabatrin—Discomfort—Paclitaxel—kidney cancer	0.000474	0.000598	CcSEcCtD
Vigabatrin—Fatigue—Gemcitabine—kidney cancer	0.000474	0.000597	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Vincristine—kidney cancer	0.000474	0.000597	CcSEcCtD
Vigabatrin—Dizziness—Sorafenib—kidney cancer	0.000471	0.000593	CcSEcCtD
Vigabatrin—Constipation—Gemcitabine—kidney cancer	0.00047	0.000592	CcSEcCtD
Vigabatrin—Pain—Gemcitabine—kidney cancer	0.00047	0.000592	CcSEcCtD
Vigabatrin—Nausea—Erlotinib—kidney cancer	0.00047	0.000592	CcSEcCtD
Vigabatrin—Mood swings—Doxorubicin—kidney cancer	0.000469	0.000591	CcSEcCtD
Vigabatrin—Diarrhoea—Sunitinib—kidney cancer	0.000469	0.000591	CcSEcCtD
Vigabatrin—Ataxia—Doxorubicin—kidney cancer	0.000466	0.000587	CcSEcCtD
Vigabatrin—Mental disorder—Capecitabine—kidney cancer	0.000466	0.000587	CcSEcCtD
Vigabatrin—Asthenia—Dactinomycin—kidney cancer	0.000465	0.000586	CcSEcCtD
Vigabatrin—Confusional state—Paclitaxel—kidney cancer	0.000464	0.000585	CcSEcCtD
Vigabatrin—Malnutrition—Capecitabine—kidney cancer	0.000463	0.000583	CcSEcCtD
Vigabatrin—Oedema—Paclitaxel—kidney cancer	0.00046	0.00058	CcSEcCtD
Vigabatrin—Abdominal pain—Vincristine—kidney cancer	0.000458	0.000577	CcSEcCtD
Vigabatrin—Body temperature increased—Vincristine—kidney cancer	0.000458	0.000577	CcSEcCtD
Vigabatrin—Infection—Paclitaxel—kidney cancer	0.000457	0.000576	CcSEcCtD
Vigabatrin—Dizziness—Sunitinib—kidney cancer	0.000453	0.000571	CcSEcCtD
Vigabatrin—Feeling abnormal—Gemcitabine—kidney cancer	0.000453	0.000571	CcSEcCtD
Vigabatrin—Vomiting—Sorafenib—kidney cancer	0.000453	0.00057	CcSEcCtD
Vigabatrin—Abdominal pain upper—Doxorubicin—kidney cancer	0.000452	0.00057	CcSEcCtD
Vigabatrin—Nervous system disorder—Paclitaxel—kidney cancer	0.000451	0.000569	CcSEcCtD
Vigabatrin—Rash—Sorafenib—kidney cancer	0.000449	0.000566	CcSEcCtD
Vigabatrin—Dermatitis—Sorafenib—kidney cancer	0.000448	0.000565	CcSEcCtD
Vigabatrin—Back pain—Capecitabine—kidney cancer	0.000447	0.000564	CcSEcCtD
Vigabatrin—Breast disorder—Doxorubicin—kidney cancer	0.000447	0.000564	CcSEcCtD
Vigabatrin—Skin disorder—Paclitaxel—kidney cancer	0.000447	0.000563	CcSEcCtD
Vigabatrin—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000446	0.000562	CcSEcCtD
Vigabatrin—Headache—Sorafenib—kidney cancer	0.000446	0.000562	CcSEcCtD
Vigabatrin—Muscle spasms—Capecitabine—kidney cancer	0.000445	0.000561	CcSEcCtD
Vigabatrin—Diarrhoea—Dactinomycin—kidney cancer	0.000444	0.000559	CcSEcCtD
Vigabatrin—Nasopharyngitis—Doxorubicin—kidney cancer	0.000443	0.000558	CcSEcCtD
Vigabatrin—Vision blurred—Capecitabine—kidney cancer	0.000436	0.00055	CcSEcCtD
Vigabatrin—Vomiting—Sunitinib—kidney cancer	0.000435	0.000549	CcSEcCtD
Vigabatrin—Body temperature increased—Gemcitabine—kidney cancer	0.000434	0.000548	CcSEcCtD
Vigabatrin—Tremor—Capecitabine—kidney cancer	0.000433	0.000546	CcSEcCtD
Vigabatrin—Rash—Sunitinib—kidney cancer	0.000432	0.000544	CcSEcCtD
Vigabatrin—Dermatitis—Sunitinib—kidney cancer	0.000431	0.000544	CcSEcCtD
Vigabatrin—Abdominal distension—Doxorubicin—kidney cancer	0.000431	0.000543	CcSEcCtD
Vigabatrin—Ill-defined disorder—Capecitabine—kidney cancer	0.000429	0.000541	CcSEcCtD
Vigabatrin—Headache—Sunitinib—kidney cancer	0.000429	0.000541	CcSEcCtD
Vigabatrin—Influenza—Doxorubicin—kidney cancer	0.000428	0.00054	CcSEcCtD
Vigabatrin—Anaemia—Capecitabine—kidney cancer	0.000428	0.000539	CcSEcCtD
Vigabatrin—Hypersensitivity—Vincristine—kidney cancer	0.000427	0.000538	CcSEcCtD
Vigabatrin—Nausea—Sorafenib—kidney cancer	0.000423	0.000533	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000419	0.000528	CcSEcCtD
Vigabatrin—Malaise—Capecitabine—kidney cancer	0.000417	0.000526	CcSEcCtD
Vigabatrin—Insomnia—Paclitaxel—kidney cancer	0.000416	0.000525	CcSEcCtD
Vigabatrin—Vertigo—Capecitabine—kidney cancer	0.000416	0.000524	CcSEcCtD
Vigabatrin—Asthenia—Vincristine—kidney cancer	0.000416	0.000524	CcSEcCtD
Vigabatrin—Paraesthesia—Paclitaxel—kidney cancer	0.000413	0.000521	CcSEcCtD
Vigabatrin—Vomiting—Dactinomycin—kidney cancer	0.000412	0.00052	CcSEcCtD
Vigabatrin—Bronchitis—Doxorubicin—kidney cancer	0.000412	0.000519	CcSEcCtD
Vigabatrin—Somnolence—Paclitaxel—kidney cancer	0.000409	0.000516	CcSEcCtD
Vigabatrin—Rash—Dactinomycin—kidney cancer	0.000409	0.000515	CcSEcCtD
Vigabatrin—Nausea—Sunitinib—kidney cancer	0.000407	0.000513	CcSEcCtD
Vigabatrin—Dyspepsia—Paclitaxel—kidney cancer	0.000405	0.000511	CcSEcCtD
Vigabatrin—Cough—Capecitabine—kidney cancer	0.000404	0.000509	CcSEcCtD
Vigabatrin—Decreased appetite—Paclitaxel—kidney cancer	0.0004	0.000504	CcSEcCtD
Vigabatrin—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000398	0.000501	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000397	0.000501	CcSEcCtD
Vigabatrin—Fatigue—Paclitaxel—kidney cancer	0.000397	0.0005	CcSEcCtD
Vigabatrin—Diarrhoea—Vincristine—kidney cancer	0.000396	0.0005	CcSEcCtD
Vigabatrin—Asthenia—Gemcitabine—kidney cancer	0.000394	0.000497	CcSEcCtD
Vigabatrin—Chest pain—Capecitabine—kidney cancer	0.000394	0.000497	CcSEcCtD
Vigabatrin—Myalgia—Capecitabine—kidney cancer	0.000394	0.000497	CcSEcCtD
Vigabatrin—Arthralgia—Capecitabine—kidney cancer	0.000394	0.000497	CcSEcCtD
Vigabatrin—Constipation—Paclitaxel—kidney cancer	0.000393	0.000496	CcSEcCtD
Vigabatrin—Pain—Paclitaxel—kidney cancer	0.000393	0.000496	CcSEcCtD
Vigabatrin—Anxiety—Capecitabine—kidney cancer	0.000392	0.000495	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000391	0.000493	CcSEcCtD
Vigabatrin—Weight increased—Doxorubicin—kidney cancer	0.000389	0.000491	CcSEcCtD
Vigabatrin—Discomfort—Capecitabine—kidney cancer	0.000389	0.000491	CcSEcCtD
Vigabatrin—Pruritus—Gemcitabine—kidney cancer	0.000389	0.00049	CcSEcCtD
Vigabatrin—Nausea—Dactinomycin—kidney cancer	0.000385	0.000485	CcSEcCtD
Vigabatrin—Pneumonia—Doxorubicin—kidney cancer	0.000384	0.000484	CcSEcCtD
Vigabatrin—Dizziness—Vincristine—kidney cancer	0.000383	0.000483	CcSEcCtD
Vigabatrin—Drowsiness—Doxorubicin—kidney cancer	0.000382	0.000481	CcSEcCtD
Vigabatrin—Infestation NOS—Doxorubicin—kidney cancer	0.000382	0.000481	CcSEcCtD
Vigabatrin—Infestation—Doxorubicin—kidney cancer	0.000382	0.000481	CcSEcCtD
Vigabatrin—Confusional state—Capecitabine—kidney cancer	0.000381	0.00048	CcSEcCtD
Vigabatrin—Feeling abnormal—Paclitaxel—kidney cancer	0.000379	0.000478	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000378	0.000477	CcSEcCtD
Vigabatrin—Oedema—Capecitabine—kidney cancer	0.000378	0.000476	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000376	0.000474	CcSEcCtD
Vigabatrin—Diarrhoea—Gemcitabine—kidney cancer	0.000376	0.000474	CcSEcCtD
Vigabatrin—Infection—Capecitabine—kidney cancer	0.000375	0.000473	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000374	0.000472	CcSEcCtD
Vigabatrin—Conjunctivitis—Doxorubicin—kidney cancer	0.000371	0.000468	CcSEcCtD
Vigabatrin—Urinary tract infection—Doxorubicin—kidney cancer	0.000371	0.000468	CcSEcCtD
Vigabatrin—Nervous system disorder—Capecitabine—kidney cancer	0.00037	0.000467	CcSEcCtD
Vigabatrin—Vomiting—Vincristine—kidney cancer	0.000368	0.000464	CcSEcCtD
Vigabatrin—Skin disorder—Capecitabine—kidney cancer	0.000367	0.000462	CcSEcCtD
Vigabatrin—Urticaria—Paclitaxel—kidney cancer	0.000365	0.000461	CcSEcCtD
Vigabatrin—Rash—Vincristine—kidney cancer	0.000365	0.00046	CcSEcCtD
Vigabatrin—Dermatitis—Vincristine—kidney cancer	0.000365	0.00046	CcSEcCtD
Vigabatrin—Abdominal pain—Paclitaxel—kidney cancer	0.000364	0.000458	CcSEcCtD
Vigabatrin—Body temperature increased—Paclitaxel—kidney cancer	0.000364	0.000458	CcSEcCtD
Vigabatrin—Headache—Vincristine—kidney cancer	0.000363	0.000457	CcSEcCtD
Vigabatrin—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000361	0.000455	CcSEcCtD
Vigabatrin—Sinusitis—Doxorubicin—kidney cancer	0.000358	0.000451	CcSEcCtD
Vigabatrin—Vomiting—Gemcitabine—kidney cancer	0.000349	0.00044	CcSEcCtD
Vigabatrin—Rash—Gemcitabine—kidney cancer	0.000346	0.000437	CcSEcCtD
Vigabatrin—Dermatitis—Gemcitabine—kidney cancer	0.000346	0.000436	CcSEcCtD
Vigabatrin—Headache—Gemcitabine—kidney cancer	0.000344	0.000434	CcSEcCtD
Vigabatrin—Nausea—Vincristine—kidney cancer	0.000344	0.000434	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000344	0.000434	CcSEcCtD
Vigabatrin—Insomnia—Capecitabine—kidney cancer	0.000341	0.00043	CcSEcCtD
Vigabatrin—Hypoaesthesia—Doxorubicin—kidney cancer	0.000341	0.00043	CcSEcCtD
Vigabatrin—Paraesthesia—Capecitabine—kidney cancer	0.000339	0.000427	CcSEcCtD
Vigabatrin—Hypersensitivity—Paclitaxel—kidney cancer	0.000339	0.000427	CcSEcCtD
Vigabatrin—Oedema peripheral—Doxorubicin—kidney cancer	0.000337	0.000425	CcSEcCtD
Vigabatrin—Connective tissue disorder—Doxorubicin—kidney cancer	0.000337	0.000424	CcSEcCtD
Vigabatrin—Dyspepsia—Capecitabine—kidney cancer	0.000332	0.000419	CcSEcCtD
Vigabatrin—Visual impairment—Doxorubicin—kidney cancer	0.00033	0.000416	CcSEcCtD
Vigabatrin—Asthenia—Paclitaxel—kidney cancer	0.00033	0.000416	CcSEcCtD
Vigabatrin—Decreased appetite—Capecitabine—kidney cancer	0.000328	0.000414	CcSEcCtD
Vigabatrin—Nausea—Gemcitabine—kidney cancer	0.000326	0.000411	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000326	0.000411	CcSEcCtD
Vigabatrin—Fatigue—Capecitabine—kidney cancer	0.000326	0.00041	CcSEcCtD
Vigabatrin—Pruritus—Paclitaxel—kidney cancer	0.000325	0.00041	CcSEcCtD
Vigabatrin—Erythema multiforme—Doxorubicin—kidney cancer	0.000324	0.000408	CcSEcCtD
Vigabatrin—Constipation—Capecitabine—kidney cancer	0.000323	0.000407	CcSEcCtD
Vigabatrin—Pain—Capecitabine—kidney cancer	0.000323	0.000407	CcSEcCtD
Vigabatrin—Eye disorder—Doxorubicin—kidney cancer	0.00032	0.000404	CcSEcCtD
Vigabatrin—Tinnitus—Doxorubicin—kidney cancer	0.000319	0.000403	CcSEcCtD
Vigabatrin—Diarrhoea—Paclitaxel—kidney cancer	0.000315	0.000397	CcSEcCtD
Vigabatrin—Feeling abnormal—Capecitabine—kidney cancer	0.000311	0.000392	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Capecitabine—kidney cancer	0.000309	0.000389	CcSEcCtD
Vigabatrin—Dizziness—Paclitaxel—kidney cancer	0.000304	0.000384	CcSEcCtD
Vigabatrin—Mental disorder—Doxorubicin—kidney cancer	0.0003	0.000378	CcSEcCtD
Vigabatrin—Urticaria—Capecitabine—kidney cancer	0.0003	0.000378	CcSEcCtD
Vigabatrin—Body temperature increased—Capecitabine—kidney cancer	0.000298	0.000376	CcSEcCtD
Vigabatrin—Abdominal pain—Capecitabine—kidney cancer	0.000298	0.000376	CcSEcCtD
Vigabatrin—Malnutrition—Doxorubicin—kidney cancer	0.000298	0.000376	CcSEcCtD
Vigabatrin—Tension—Doxorubicin—kidney cancer	0.000293	0.000369	CcSEcCtD
Vigabatrin—Vomiting—Paclitaxel—kidney cancer	0.000293	0.000369	CcSEcCtD
Vigabatrin—Rash—Paclitaxel—kidney cancer	0.00029	0.000366	CcSEcCtD
Vigabatrin—Dermatitis—Paclitaxel—kidney cancer	0.00029	0.000365	CcSEcCtD
Vigabatrin—Nervousness—Doxorubicin—kidney cancer	0.00029	0.000365	CcSEcCtD
Vigabatrin—Back pain—Doxorubicin—kidney cancer	0.000288	0.000364	CcSEcCtD
Vigabatrin—Headache—Paclitaxel—kidney cancer	0.000288	0.000363	CcSEcCtD
Vigabatrin—Muscle spasms—Doxorubicin—kidney cancer	0.000287	0.000361	CcSEcCtD
Vigabatrin—Vision blurred—Doxorubicin—kidney cancer	0.000281	0.000354	CcSEcCtD
Vigabatrin—Hypersensitivity—Capecitabine—kidney cancer	0.000278	0.000351	CcSEcCtD
Vigabatrin—Ill-defined disorder—Doxorubicin—kidney cancer	0.000277	0.000349	CcSEcCtD
Vigabatrin—Anaemia—Doxorubicin—kidney cancer	0.000276	0.000347	CcSEcCtD
Vigabatrin—Agitation—Doxorubicin—kidney cancer	0.000274	0.000345	CcSEcCtD
Vigabatrin—Nausea—Paclitaxel—kidney cancer	0.000273	0.000345	CcSEcCtD
Vigabatrin—Asthenia—Capecitabine—kidney cancer	0.000271	0.000341	CcSEcCtD
Vigabatrin—Malaise—Doxorubicin—kidney cancer	0.000269	0.000339	CcSEcCtD
Vigabatrin—Vertigo—Doxorubicin—kidney cancer	0.000268	0.000338	CcSEcCtD
Vigabatrin—Pruritus—Capecitabine—kidney cancer	0.000267	0.000337	CcSEcCtD
Vigabatrin—Cough—Doxorubicin—kidney cancer	0.00026	0.000328	CcSEcCtD
Vigabatrin—Convulsion—Doxorubicin—kidney cancer	0.000258	0.000326	CcSEcCtD
Vigabatrin—Diarrhoea—Capecitabine—kidney cancer	0.000258	0.000326	CcSEcCtD
Vigabatrin—Myalgia—Doxorubicin—kidney cancer	0.000254	0.00032	CcSEcCtD
Vigabatrin—Arthralgia—Doxorubicin—kidney cancer	0.000254	0.00032	CcSEcCtD
Vigabatrin—Chest pain—Doxorubicin—kidney cancer	0.000254	0.00032	CcSEcCtD
Vigabatrin—Anxiety—Doxorubicin—kidney cancer	0.000253	0.000319	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000252	0.000318	CcSEcCtD
Vigabatrin—Discomfort—Doxorubicin—kidney cancer	0.000251	0.000316	CcSEcCtD
Vigabatrin—Dizziness—Capecitabine—kidney cancer	0.00025	0.000315	CcSEcCtD
Vigabatrin—Confusional state—Doxorubicin—kidney cancer	0.000245	0.000309	CcSEcCtD
Vigabatrin—Oedema—Doxorubicin—kidney cancer	0.000243	0.000307	CcSEcCtD
Vigabatrin—Infection—Doxorubicin—kidney cancer	0.000242	0.000305	CcSEcCtD
Vigabatrin—Vomiting—Capecitabine—kidney cancer	0.00024	0.000303	CcSEcCtD
Vigabatrin—Nervous system disorder—Doxorubicin—kidney cancer	0.000239	0.000301	CcSEcCtD
Vigabatrin—Rash—Capecitabine—kidney cancer	0.000238	0.0003	CcSEcCtD
Vigabatrin—Dermatitis—Capecitabine—kidney cancer	0.000238	0.0003	CcSEcCtD
Vigabatrin—Headache—Capecitabine—kidney cancer	0.000237	0.000298	CcSEcCtD
Vigabatrin—Skin disorder—Doxorubicin—kidney cancer	0.000236	0.000298	CcSEcCtD
Vigabatrin—Nausea—Capecitabine—kidney cancer	0.000224	0.000283	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000222	0.00028	CcSEcCtD
Vigabatrin—Insomnia—Doxorubicin—kidney cancer	0.00022	0.000277	CcSEcCtD
Vigabatrin—Paraesthesia—Doxorubicin—kidney cancer	0.000219	0.000275	CcSEcCtD
Vigabatrin—Somnolence—Doxorubicin—kidney cancer	0.000216	0.000273	CcSEcCtD
Vigabatrin—Dyspepsia—Doxorubicin—kidney cancer	0.000214	0.00027	CcSEcCtD
Vigabatrin—Decreased appetite—Doxorubicin—kidney cancer	0.000212	0.000267	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.00021	0.000265	CcSEcCtD
Vigabatrin—Fatigue—Doxorubicin—kidney cancer	0.00021	0.000265	CcSEcCtD
Vigabatrin—Pain—Doxorubicin—kidney cancer	0.000208	0.000262	CcSEcCtD
Vigabatrin—Constipation—Doxorubicin—kidney cancer	0.000208	0.000262	CcSEcCtD
Vigabatrin—Feeling abnormal—Doxorubicin—kidney cancer	0.000201	0.000253	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000199	0.000251	CcSEcCtD
Vigabatrin—Urticaria—Doxorubicin—kidney cancer	0.000193	0.000244	CcSEcCtD
Vigabatrin—Body temperature increased—Doxorubicin—kidney cancer	0.000192	0.000243	CcSEcCtD
Vigabatrin—Abdominal pain—Doxorubicin—kidney cancer	0.000192	0.000243	CcSEcCtD
Vigabatrin—Hypersensitivity—Doxorubicin—kidney cancer	0.000179	0.000226	CcSEcCtD
Vigabatrin—Asthenia—Doxorubicin—kidney cancer	0.000175	0.00022	CcSEcCtD
Vigabatrin—Pruritus—Doxorubicin—kidney cancer	0.000172	0.000217	CcSEcCtD
Vigabatrin—Diarrhoea—Doxorubicin—kidney cancer	0.000167	0.00021	CcSEcCtD
Vigabatrin—Dizziness—Doxorubicin—kidney cancer	0.000161	0.000203	CcSEcCtD
Vigabatrin—Vomiting—Doxorubicin—kidney cancer	0.000155	0.000195	CcSEcCtD
Vigabatrin—Rash—Doxorubicin—kidney cancer	0.000153	0.000193	CcSEcCtD
Vigabatrin—Dermatitis—Doxorubicin—kidney cancer	0.000153	0.000193	CcSEcCtD
Vigabatrin—Headache—Doxorubicin—kidney cancer	0.000152	0.000192	CcSEcCtD
Vigabatrin—Nausea—Doxorubicin—kidney cancer	0.000145	0.000182	CcSEcCtD
